HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Sebastien Lorenzo Selected Research

asciminib

11/2022Exposure-Efficacy Analysis of Asciminib in Philadelphia Chromosome-Positive Chronic Myeloid Leukemia in Chronic Phase.
10/2022Population Pharmacokinetics of Asciminib in Tyrosine Kinase Inhibitor-Treated Patients with Philadelphia Chromosome-Positive Chronic Myeloid Leukemia in Chronic and Acute Phases.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Sebastien Lorenzo Research Topics

Disease

2BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
11/2022 - 10/2022
2Philadelphia Chromosome
11/2022 - 10/2022
2Systemic Mastocytosis
12/2013 - 05/2012
2Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
12/2013 - 05/2012
1Disease Progression
11/2022

Drug/Important Bio-Agent (IBA)

2asciminibIBA
11/2022 - 10/2022
2bosutinibIBA
11/2022 - 10/2022
2Tyrosine Kinase InhibitorsIBA
10/2022 - 12/2013
2midostaurinIBA
12/2013 - 05/2012
1Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
12/2013